Company Contents
Quick Facts & Snapshot
Summary
The cell harvesting market is entering a strong expansion phase, driven by regenerative medicine, cell and gene therapies, and higher bioprocess efficiency demands. Leading Cell Harvesting market companies are consolidating share through automation, closed-system workflows, and single-use technologies. Global market value is projected to rise from US$ 4.80 Billion in 2025 to US$ 9.93 Billion by 2032, reflecting a 10.80% CAGR.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
Rankings of Cell Harvesting market companies are based on a composite scoring model combining quantitative and qualitative factors. Core criteria include 2025 cell harvesting revenue, 3-year growth trajectory, and share of global bioprocess equipment sales. We also assess competitive wins in biopharma and CDMO projects, installed base of harvesters and consumables, and breadth of product portfolio across automated systems, kits, and single-use components. Technology differentiation weighs advances in closed systems, sterility assurance, process analytics, and integration with upstream and downstream workflows. Service coverage considers global field support, validation expertise, and ability to manage long-term maintenance, calibration, and lifecycle management contracts. Scores are normalized to ensure comparability between diversified life-science conglomerates and specialized pure plays, and final ranking reflects the weighted average of all pillars.
Top 10 Companies in Cell Harvesting
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Thermo Fisher Scientific Inc.
Global life-science leader providing end-to-end bioprocess and cell therapy solutions, including advanced automated cell harvesting platforms.
Beckman Coulter Life Sciences
Specialist in centrifugation and lab automation delivering reliable cell harvesting solutions from discovery to commercial manufacturing scale.
Sartorius AG
European bioprocess powerhouse offering integrated single-use bioreactor, filtration, and cell harvesting platforms for scalable biologics production.
Merck KGaA (MilliporeSigma)
Diversified life-science company with strong downstream and clarification solutions supporting efficient, scalable cell harvesting workflows.
GE HealthCare (formerly Cytiva business overlaps)
Major bioprocess technology supplier with harvest platforms integrated into upstream and downstream processing environments.
Eppendorf SE
Trusted provider of centrifuges and small-scale bioprocess equipment serving research, pilot, and clinical cell harvesting needs.
Terumo Blood and Cell Technologies
Clinical-focused provider of blood and cell processing technologies supporting therapeutic cell collection and harvesting.
Miltenyi Biotec B.V. & Co. KG
Innovation-driven company specializing in magnetic cell separation and automated harvest solutions from research to clinical scale.
Corning Incorporated (Life Sciences)
Key supplier of advanced cell culture vessels and systems designed for efficient, gentle cell harvesting.
Bio-Techne Corporation
Growing player providing reagents and instruments that enable precise small-scale cell harvesting and characterization.
SWOT Leaders
Thermo Fisher Scientific Inc.
SWOT Snapshot
Comprehensive end-to-end workflows, strong global footprint, and deep relationships with leading cell and gene therapy sponsors.
Complex portfolio can challenge smaller customers and pricing is often higher than regional competitors.
Commercialization of new CAR-T and gene therapies requiring standardized, automated closed cell harvesting solutions.
Intensifying competition from agile specialists and potential regulatory shifts affecting integrated platform approvals.
Beckman Coulter Life Sciences
SWOT Snapshot
Large installed base of centrifuges, proven reliability, and strong automation capabilities supporting scalable cell harvesting.
Less comprehensive offering in single-use and filtration-based harvesting compared with some European rivals.
Upgrade cycle for legacy centrifuges to connected, data-rich models in biopharma and CDMO facilities worldwide.
Price pressure from lower-cost manufacturers and risk of technology disruption from non-centrifugation harvest methods.
Sartorius AG
SWOT Snapshot
Leadership in single-use bioprocessing, integrated bioreactor-to-harvest solutions, and strong presence in biosimilar manufacturing.
High exposure to European macroeconomic cycles and procurement budget fluctuations.
Rapid expansion of biologics and biosimilar capacity in Asia requiring scalable single-use harvest platforms.
Currency volatility, regulatory scrutiny on single-use waste, and increasing competition from Asian bioprocess vendors.
Cell Harvesting Market Regional Competitive Landscape
North America remains the largest revenue contributor for Cell Harvesting market companies, driven by strong biologics pipelines, high R&D intensity, and early adoption of cell and gene therapies. Thermo Fisher Scientific Inc., Beckman Coulter Life Sciences, and Terumo Blood and Cell Technologies hold a dominant presence, supported by dense CDMO networks and advanced academic medical centers.
Europe shows robust, innovation-led growth with strong emphasis on single-use technologies, sustainable operations, and regulatory compliance. Sartorius AG, Merck KGaA (MilliporeSigma), and Miltenyi Biotec anchor regional competition. EU funding for advanced therapies and biosimilar production underpins demand for integrated, closed cell harvesting solutions across Germany, France, the UK, and Nordic countries.
Asia Pacific is the fastest-growing region for Cell Harvesting market companies, fueled by expanding biologics capacity in China, South Korea, India, and Singapore. Sartorius AG and GE HealthCare increasingly localize manufacturing and service to compete with emerging regional vendors. Government-backed investments in biosimilars and vaccines create sustained demand for scalable harvest platforms.
Latin America remains a smaller but strategically important growth frontier, with Brazil and Mexico leading adoption of modern bioprocessing. Global Cell Harvesting market companies often pursue distributor-led models and targeted partnerships with regional biopharma and vaccine institutes. Upgrades from legacy equipment to automated, closed systems present a key medium-term opportunity.
The Middle East and Africa region is at an earlier stage but gaining momentum through investments in healthcare infrastructure and vaccine self-sufficiency. Gulf states sponsor new biologics and fill-finish plants, attracting Thermo Fisher Scientific Inc. and Merck KGaA (MilliporeSigma). Over time, these projects will demand higher volumes of reliable cell harvesting and clarification systems.
Across all regions, regulatory expectations around sterility, data integrity, and patient safety are converging upward. Cell Harvesting market companies that offer validated, GMP-ready platforms, strong local service, and digital integration for process analytics are best positioned to win multinational tenders and long-term framework agreements.
Cell Harvesting Market Emerging Challengers & Disruptive Start-Ups
Emerging Challengers & Disruptive Start-Ups
Developing microfluidic-based continuous cell harvesting platforms that reduce shear stress and media consumption for small and mid-scale bioreactors.
Offers AI-optimized filtration cartridges and disposable harvest manifolds that dynamically adjust flow to maximize cell viability and product yield.
Focuses on closed, modular cell therapy harvesting units designed for hospital-based manufacturing and decentralized production models.
Delivers cost-efficient single-use harvest skids tailored to emerging-market biosimilar manufacturers, emphasizing local service and flexible financing models.
Provides a cloud-native analytics layer that connects to existing harvest hardware, enabling predictive maintenance and real-time process optimization.
Combines inline optical sensors with machine learning to monitor harvest quality, targeting integration with leading Cell Harvesting market companies’ platforms.
Cell Harvesting Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Cell Harvesting market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Cell Harvestingmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.